Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

CAMERA - complete assessment of elderly patients with cancer: A non-randomised feasibility study.

Jackson G, Gabe R, Johnson M, Date K, Harman D, Maraveyas A, Roy R, Lind MJ.

J Geriatr Oncol. 2018 Jul 21. pii: S1879-4068(18)30036-5. doi: 10.1016/j.jgo.2018.07.005. [Epub ahead of print] No abstract available.

PMID:
30041980
2.

The Effects of a BDNF Val66Met Polymorphism on Posttraumatic Stress Disorder: A Meta-Analysis.

Bountress KE, Bacanu SA, Tomko RL, Korte KJ, Hicks T, Sheerin C, Lind MJ, Marraccini M, Nugent N, Amstadter AB.

Neuropsychobiology. 2017;76(3):136-142. doi: 10.1159/000489407. Epub 2018 Jun 6.

PMID:
29874672
3.

Relation between coping and posttrauma cognitions on PTSD in a combat-trauma population.

Sheerin CM, Chowdhury N, Lind MJ, Kurtz ED, Rappaport LM, Berenz EC, Brown RC, Pickett T, McDonald SD, Danielson CK, Amstadter AB.

Mil Psychol. 2018;30(2):98-107. doi: 10.1080/08995605.2017.1420980. Epub 2018 Apr 4.

PMID:
29785065
4.

Effects of social support on the association between precollege sexual assault and college-onset victimization.

Hawn SE, Lind MJ, Conley A, Overstreet CM, Kendler KS, Dick DM, Amstadter AB.

J Am Coll Health. 2018 Feb 6:1-9. doi: 10.1080/07448481.2018.1431911. [Epub ahead of print]

PMID:
29405876
5.

The impact of resilience and subsequent stressful life events on MDD and GAD.

Sheerin CM, Lind MJ, Brown EA, Gardner CO, Kendler KS, Amstadter AB.

Depress Anxiety. 2018 Feb;35(2):140-147. doi: 10.1002/da.22700. Epub 2017 Nov 24.

6.

MicroRNA-31 Regulates Chemosensitivity in Malignant Pleural Mesothelioma.

Moody HL, Lind MJ, Maher SG.

Mol Ther Nucleic Acids. 2017 Sep 15;8:317-329. doi: 10.1016/j.omtn.2017.07.001. Epub 2017 Jul 8.

7.

The genetics and epigenetics of PTSD: overview, recent advances, and future directions.

Sheerin CM, Lind MJ, Bountress KE, Nugent NR, Amstadter AB.

Curr Opin Psychol. 2017 Apr;14:5-11. doi: 10.1016/j.copsyc.2016.09.003. Epub 2016 Sep 28. Review.

PMID:
28813320
8.

Association of Posttraumatic Stress Disorder With rs2267735 in the ADCYAP1R1 Gene: A Meta-Analysis.

Lind MJ, Marraccini ME, Sheerin CM, Bountress K, Bacanu SA, Amstadter AB, Nugent NR.

J Trauma Stress. 2017 Aug;30(4):389-398. doi: 10.1002/jts.22211. Epub 2017 Jul 26. Review.

9.

Relationships between potentially traumatic events, sleep disturbances, and symptoms of PTSD and alcohol use disorder in a young adult sample.

Lind MJ, Baylor A, Overstreet CM, Hawn SE, Rybarczyk BD, Kendler KS, Dick DM, Amstadter AB.

Sleep Med. 2017 Jun;34:141-147. doi: 10.1016/j.sleep.2017.02.024. Epub 2017 Mar 18.

10.

Does Parenting Influence the Enduring Impact of Severe Childhood Sexual Abuse on Psychiatric Resilience in Adulthood?

Lind MJ, Brown RC, Sheerin CM, York TP, Myers JM, Kendler KS, Amstadter AB.

Child Psychiatry Hum Dev. 2018 Feb;49(1):33-41. doi: 10.1007/s10578-017-0727-y.

PMID:
28488144
11.

An examination of the etiologic overlap between the genetic and environmental influences on insomnia and common psychopathology.

Lind MJ, Hawn SE, Sheerin CM, Aggen SH, Kirkpatrick RM, Kendler KS, Amstadter AB.

Depress Anxiety. 2017 May;34(5):453-462. doi: 10.1002/da.22587. Epub 2017 Jan 16.

12.

Genetic Pathways to Insomnia.

Lind MJ, Gehrman PR.

Brain Sci. 2016 Dec 20;6(4). pii: E64. doi: 10.3390/brainsci6040064. Review.

13.

Sleep Disturbances in OEF/OIF/OND Veterans: Associations with PTSD, Personality, and Coping.

Lind MJ, Brown E, Farrell-Carnahan L, Brown RC, Hawn S, Berenz E, McDonald S, Pickett T, Danielson CK, Thomas S, Amstadter AB.

J Clin Sleep Med. 2017 Feb 15;13(2):291-299. doi: 10.5664/jcsm.6466.

14.

The Genetics and Epigenetics of PTSD: Overview, Recent Advances, and Future Directions.

Sheerin CM, Lind MJ, Bountress K, Nugent NR, Amstadter AB.

Curr Opin Psychol. 2017 Apr;14:5-11.

15.

An epidemiologic study of childhood sexual abuse and adult sleep disturbances.

Lind MJ, Aggen SH, Kendler KS, York TP, Amstadter AB.

Psychol Trauma. 2016 Mar;8(2):198-205. doi: 10.1037/tra0000080. Epub 2015 Sep 21.

16.

A Longitudinal Twin Study of Insomnia Symptoms in Adults.

Lind MJ, Aggen SH, Kirkpatrick RM, Kendler KS, Amstadter AB.

Sleep. 2015 Sep 1;38(9):1423-30. doi: 10.5665/sleep.4982.

17.

The effect of emergency presentation on surgery and survival in lung cancer patients in England, 2006-2008.

Tataru D, Jack RH, Lind MJ, Møller H, Lüchtenborg M.

Cancer Epidemiol. 2015 Aug;39(4):612-6. doi: 10.1016/j.canep.2015.04.008. Epub 2015 May 13.

PMID:
25979251
18.

Merkel cell carcinoma in East Yorkshire: A case series and literature review of current management.

Jackson PC, Wallis K, Allgar V, Lind MJ, Stanley PR.

J Plast Reconstr Aesthet Surg. 2015 May;68(5):667-72. doi: 10.1016/j.bjps.2014.12.021. Epub 2015 Jan 6. Review.

PMID:
25595515
19.

Clinical response to primary letrozole therapy in elderly patients with early breast cancer: possible role for p53 as a biomarker.

Garimella V, Hussain T, Agarwal V, Radhakrishna S, Fox JN, Kneeshaw PJ, Long ED, Mahapatra TK, McManus PL, Lind MJ, Drew PJ, Cawkwell L.

Int J Surg. 2014;12(8):821-6. doi: 10.1016/j.ijsu.2014.06.009. Epub 2014 Jul 8.

20.

High procedure volume is strongly associated with improved survival after lung cancer surgery.

Lüchtenborg M, Riaz SP, Coupland VH, Lim E, Jakobsen E, Krasnik M, Page R, Lind MJ, Peake MD, Møller H.

J Clin Oncol. 2013 Sep 1;31(25):3141-6. doi: 10.1200/JCO.2013.49.0219. Epub 2013 Jul 29.

PMID:
23897962
21.

Proteomic (antibody microarray) exploration of the molecular mechanism of action of the specific COX-2 inhibitor DuP 697.

Agarwal V, Hodgkinson VC, Eagle GL, Scaife L, Lind MJ, Cawkwell L.

Int J Oncol. 2013 Mar;42(3):1088-92. doi: 10.3892/ijo.2013.1784. Epub 2013 Jan 22.

PMID:
23338544
22.

PTEN protein expression in malignant pleural mesothelioma.

Agarwal V, Campbell A, Beaumont KL, Cawkwell L, Lind MJ.

Tumour Biol. 2013 Apr;34(2):847-51. doi: 10.1007/s13277-012-0615-9. Epub 2012 Dec 15.

PMID:
23242608
23.

Pilot and feasibility study: comparative proteomic analysis by 2-DE MALDI TOF/TOF MS reveals 14-3-3 proteins as putative biomarkers of response to neoadjuvant chemotherapy in ER-positive breast cancer.

Hodgkinson VC, Agarwal V, ELFadl D, Fox JN, McManus PL, Mahapatra TK, Kneeshaw PJ, Drew PJ, Lind MJ, Cawkwell L.

J Proteomics. 2012 May 17;75(9):2745-52. doi: 10.1016/j.jprot.2012.03.049. Epub 2012 Apr 3.

PMID:
22498883
24.

Proteomic identification of predictive biomarkers of resistance to neoadjuvant chemotherapy in luminal breast cancer: a possible role for 14-3-3 theta/tau and tBID?

Hodgkinson VC, ELFadl D, Agarwal V, Garimella V, Russell C, Long ED, Fox JN, McManus PL, Mahapatra TK, Kneeshaw PJ, Drew PJ, Lind MJ, Cawkwell L.

J Proteomics. 2012 Feb 2;75(4):1276-83. doi: 10.1016/j.jprot.2011.11.005. Epub 2011 Nov 15.

PMID:
22115752
25.

Differential proteomics in the search for biomarkers of radiotherapy resistance.

Scaife L, Hodgkinson VC, Drew PJ, Lind MJ, Cawkwell L.

Expert Rev Proteomics. 2011 Aug;8(4):535-52. doi: 10.1586/EPR.11.32. Review.

PMID:
21819306
26.

A pilot study to investigate the role of the 26S proteasome in radiotherapy resistance and loco-regional recurrence following breast conserving therapy for early breast cancer.

Elfadl D, Hodgkinson VC, Long ED, Scaife L, Drew PJ, Lind MJ, Cawkwell L.

Breast. 2011 Aug;20(4):334-7. doi: 10.1016/j.breast.2011.02.017. Epub 2011 Mar 15.

PMID:
21411324
27.

Repeatedly identified differentially expressed proteins (RIDEPs) from antibody microarray proteomic analysis.

Hodgkinson VC, ElFadl D, Drew PJ, Lind MJ, Cawkwell L.

J Proteomics. 2011 May 1;74(5):698-703. doi: 10.1016/j.jprot.2011.02.014. Epub 2011 Feb 19.

PMID:
21338725
28.

Targeted epidermal growth factor receptor therapy in malignant pleural mesothelioma: where do we stand?

Agarwal V, Lind MJ, Cawkwell L.

Cancer Treat Rev. 2011 Nov;37(7):533-42. doi: 10.1016/j.ctrv.2010.11.004. Epub 2010 Dec 22. Review.

PMID:
21183281
29.

Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.

Hodgkinson VC, Eagle GL, Drew PJ, Lind MJ, Cawkwell L.

Cancer Lett. 2010 Aug 1;294(1):13-24. doi: 10.1016/j.canlet.2010.01.036. Epub 2010 Feb 21. Review.

PMID:
20176436
30.

Proteomic identification of putative biomarkers of radiotherapy resistance: a possible role for the 26S proteasome?

Smith L, Qutob O, Watson MB, Beavis AW, Potts D, Welham KJ, Garimella V, Lind MJ, Drew PJ, Cawkwell L.

Neoplasia. 2009 Nov;11(11):1194-207.

31.

Appropriate requesting of serum tumour markers.

Kilpatrick ES, Lind MJ.

BMJ. 2009 Sep 22;339:b3111. doi: 10.1136/bmj.b3111. No abstract available.

PMID:
19773324
32.

COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell lines.

O'Kane SL, Eagle GL, Greenman J, Lind MJ, Cawkwell L.

Lung Cancer. 2010 Feb;67(2):160-5. doi: 10.1016/j.lungcan.2009.04.008. Epub 2009 May 17.

PMID:
19450893
33.

Intravenous administration of CP-4055 (ELACYT) in patients with solid tumours. A Phase I study.

Dueland S, Aamdal S, Lind MJ, Thomas H, Sandvold ML, Gaullier JM, Rasch W.

Acta Oncol. 2009;48(1):137-45. doi: 10.1080/02841860802183620.

PMID:
18607882
34.

The proteomic analysis of cisplatin resistance in breast cancer cells.

Smith L, Welham KJ, Watson MB, Drew PJ, Lind MJ, Cawkwell L.

Oncol Res. 2007;16(11):497-506.

PMID:
18306929
35.

The putative roles of the ubiquitin/proteasome pathway in resistance to anticancer therapy.

Smith L, Lind MJ, Drew PJ, Cawkwell L.

Eur J Cancer. 2007 Nov;43(16):2330-8. Epub 2007 Sep 20. Review.

PMID:
17888650
36.

Establishment of in-vitro models of chemotherapy resistance.

Watson MB, Lind MJ, Cawkwell L.

Anticancer Drugs. 2007 Aug;18(7):749-54. Review.

PMID:
17581296
37.

Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model.

Watson MB, Lind MJ, Smith L, Drew PJ, Cawkwell L.

Acta Oncol. 2007;46(5):651-8.

PMID:
17562441
38.

The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays.

Smith L, Watson MB, O'Kane SL, Drew PJ, Lind MJ, Cawkwell L.

Mol Cancer Ther. 2006 Aug;5(8):2115-20.

39.

Expression of bcl-2 family members in malignant pleural mesothelioma.

O'Kane SL, Pound RJ, Campbell A, Chaudhuri N, Lind MJ, Cawkwell L.

Acta Oncol. 2006;45(4):449-53.

PMID:
16760181
40.

Cancer proteomics and its application to discovery of therapy response markers in human cancer.

Smith L, Lind MJ, Welham KJ, Cawkwell L; Cancer Biology Proteomics Group.

Cancer. 2006 Jul 15;107(2):232-41. Review.

41.

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy.

Manton DJ, Chaturvedi A, Hubbard A, Lind MJ, Lowry M, Maraveyas A, Pickles MD, Tozer DJ, Turnbull LW.

Br J Cancer. 2006 Feb 13;94(3):427-35. Erratum in: Br J Cancer. 2006 May 22;94(10):1544.

42.

Hsp27 may allow prediction of the response to single-agent vinorelbine chemotherapy in non-small cell lung cancer.

Berrieman HK, Cawkwell L, O'Kane SL, Smith L, Lind MJ.

Oncol Rep. 2006 Jan;15(1):283-6.

PMID:
16328069
43.

Cyclooxygenase-2 expression predicts survival in malignant pleural mesothelioma.

O'Kane SL, Cawkwell L, Campbell A, Lind MJ.

Eur J Cancer. 2005 Jul;41(11):1645-8.

PMID:
15964184
44.

Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations.

Azzabi A, Hughes AN, Calvert PM, Plummer ER, Todd R, Griffin MJ, Lind MJ, Maraveyas A, Kelly C, Fishwick K, Calvert AH, Boddy AV.

Br J Cancer. 2005 Mar 28;92(6):1006-12.

45.

The expression of Bcl-2 family proteins differs between nonsmall cell lung carcinoma subtypes.

Berrieman HK, Smith L, O'Kane SL, Campbell A, Lind MJ, Cawkwell L.

Cancer. 2005 Apr 1;103(7):1415-9.

46.

Chromosomal alterations in breast cancer revealed by multicolour fluorescence in situ hybridization.

Watson MB, Bahia H, Ashman JN, Berrieman HK, Drew P, Lind MJ, Greenman J, Cawkwell L.

Int J Oncol. 2004 Aug;25(2):277-83.

PMID:
15254723
47.

Do beta-tubulin mutations have a role in resistance to chemotherapy?

Berrieman HK, Lind MJ, Cawkwell L.

Lancet Oncol. 2004 Mar;5(3):158-64. Review.

PMID:
15003198
48.

Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation.

Berrieman HK, Ashman JN, Cowen ME, Greenman J, Lind MJ, Cawkwell L.

Br J Cancer. 2004 Feb 23;90(4):900-5.

49.

Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF).

Batey MA, Wright JG, Azzabi A, Newell DR, Lind MJ, Calvert AH, Boddy AV.

Eur J Cancer. 2002 May;38(8):1081-9.

PMID:
12008196
50.

A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancer.

Miles DW, Smith IE, Coleman RE, Calvert AH, Lind MJ.

Eur J Cancer. 2001 Jul;37(11):1366-71.

PMID:
11435066

Supplemental Content

Support Center